AbbVie Maintains US Humira Erosion Belief As 2023 Negotiations Near

Originator Has Previously Outlined 45% Erosion ‘Plus-Or-Minus 10%’

 
• By Dean Rudge
  
Alarm clock dollar bills money
Evercore: Humira is in a strong formulary position • Source: Alexander Sánchez / Alamy Stock Photo
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products